Study Evaluates Retatrutide for Obesity with Knee Osteoarthritis | Retatrutide News

A study on retatrutide for obesity and knee osteoarthritis has been completed. This trial is part of Eli Lilly's efforts to expand its metabolic pipeline.
Clinical Trials · October 11, 2026